#InspectionProtocols
A vague Letter of Authorization could lead to costly FDA review issues—are you risking your approval by not specifying your facilities?

Click to read more!

#US #CitizenPortal #RegulatoryCompliance #InspectionProtocols #FDAGuidance #ManufacturingStandards
Specify facilities and processes in LOAs to avoid SDRs, FDA counsel says
FDA OPQ explained that LOAs must specify facilities/processes when applicants do not use every facility in a DMF; amending LOAs can resolve inspection or scope mismatches preventing approval.
citizenportal.ai
August 3, 2026 at 8:50 AM